Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children

Saudi Medical Journal

Volumn 30, Issue 12, 2009, Pages 1595-1600

  Bukhari, Elham E ^a   Al Otaibi, Fawzia E ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ABSCESS; ABSCESS DRAINAGE; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CHILD; COMMUNICABLE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT ABSCESS; ORBIT CELLULITIS; OSTEOMYELITIS; PSOAS ABSCESS; RISK FACTOR; SAUDI ARABIA; SEPSIS; SUBDURAL EMPYEMA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS;

EID: 74749101213     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gonzalez BE, Hulten KG, Dishop MK, Lamberth LB, Hammerman WA, Mason EO, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005; 41: 583-590.
2. Gonzalez BE, Martinez-Aguilar G, Hulten KG, Hammerman WA, Coss-Bu J, Avalos-Mishaan A, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115: 642-648.
3. Gonzalez BE, Teruya J, Mahoney DH Jr, Hulten KG, Edwards R, Lamberth LB, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006; 117: 1673-1679.
4. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-984.
5. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
6. Bukharie HA, Abdelhadi MS, Saeed IA, Rubaish AM, Larbi EB. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001; 40: 1-4.
7. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infec Dis 2005; 40: 1785-1791.
8. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 1999; 282: 1123-1125.
9. Miles F, Voss L, Segedin E, Anderson BJ. Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit. Arch Dis Child 2005; 90: 1274-1278.
10. Nourse C, Starr M, Munckhof W. Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health 2007; 43: 656-661.
11. Martínez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23: 701-706.
12. Moussa I, Shibl AM. Molecular characterization of methicillinresistant Staphylococcus aureus recovered from outpatient clinics in Riyadh, Saudi Arabia. Saudi Med J 2009; 30: 611-617.
13. Chen CJ, Su LH, Chiu CH, Lin TY, Wong KS, Chen YY, Huang YC. Clinical features and molecular characteristic of invasive community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Diagnostic Microbiology and Infectious Disease 2007; 59: 287-293.
14. Rutar T, Chambers HF, Crawford JB, Perdreau-Remington F, Zwick OM, Karr M, Diehn JJ, Cockerham KP. Ophthalmic manifestations of infections caused by the USA 300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology 2006; 113: 1455-1462.
15. Munckhof WJ, Kleinschmidt SL, Schooneveldt JM. Invisible clindamycin resistance in erythromycin-resistant non multiresistant methicillin-resistant Staphylococcus aureus. Pathology 2004; 36: 373-374.
16. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007; 41: 296-308.
17. Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH Jr, Hardy RD. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23: 123-127.